February 11, 2012
| Bio-IT World > The Right Decision


The Right Decision

By Melissa Kruse

Sept 15, 2003 | To create M-FISys, Gene Codes had to put its flagship software product Sequencher on hold for about a year and a half. "It's like dancing with a gorilla," says founder and CEO Howard Cash. "You don't stop when you're tired. You stop when the gorilla is tired. We're not done until the city says we're done."

First released in 1991, Sequencher has become the industry standard for DNA sequencing, and was an important tool in the early stages of the Human Genome Project. Indeed, some of M-FISys was based on Sequencher, but it was mostly built from scratch. The company, which was founded by Cash in 1988, has also created software used by the U.S. Army and the FBI for identifying old war remains and helping the government use DNA samples to identify criminals.

Gene Codes was profitable for 39 consecutive quarters before embarking on M-FISys. Cash set up Gene Codes Forensics Inc., a wholly owned subsidiary of Gene Codes, to create M-FISys, while protecting the rest of the company's assets. Gene Codes signed a three-year, $10-million contract with New York City but will bill for only real hours and expenses — already close to $7 million.

"We made a decision early on not to try to profiteer on this project," Cash says. "We honestly thought we would be working on this for a year at the most." The company will probably see some paper profit eventually, but that will compensate for losses incurred by the pause in Sequencher development. "You don't make money selling software, you make money selling upgrades," Cash says.

Sales manager Carol Carriere says the company "knew it would put a strain on [Sequencher] sales, but the real loss wasn't financial. We lost time for development, and that gave our competitors a chance to catch up."

Even though it will take time before most staff members can refocus their efforts on Sequencher, Cash has no regrets. "If in the process we had brought some comfort to these hundreds and hundreds of families, but in the end we had lost the company, I would still have thought we had made a good investment and the right decision."

Back to Soul Searching 



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .